HALO - breakout alertI see very nice kind of VCP.
53 - key lvl.
53.70 - potential resist.
Target here is at least 55.65
HALO
HALO - could be coiling up Halo looks like it's preparing for the next push up.
Details on the chart.
Good luck traders
HALO - Aggressive BullishnessPrice has climbed and poised itself high above lower dominant trend line
I interpret this price structure right now as a flag, that will lead to further upsides for HALO
This I have tried to plot with the Bars Pattern tool in green
Halo Collective BottomChart painting from the early 21st century, artist Maxi Scalibusa. No investment advice or a recommendation to buy or sell any securities. This is entertainment. Start 0.115 CAD
HALO Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
HALO - Potential 5th ElliottWave Swing Trading OpportunityUsing our Elliott Wave Indicator Suite for the TradingView Platform we have identified a potential Long 5th Wave Swing Trading Opportunity for HALO on the Daily time frame . The 5th wave move in an elliottwave sequence is the highest probability move. The large impulse moves, waves 1 and 3, were obvious news events with large volume. The volume on the wave 4 pull back has stared to run out of juice, which is a good sign.
The wave 4 pull back has found support in the Red zone of our probability pullback zones, which represents an 75% probability that our automated 5th wave target zone, in blue on the chart, will be hit. Further more the profit taking pull back is at major support and resistance zone from previous range period.
We see yellow dots formed in the overbought zone on our special False Breakout Stochastic indicator, which signals strong Bullish momentum. When, during a wave 4 pullback, the stochastic pulls back against these false break out dots and crosses in the oversold zone, there is a high probability the stocks price action will resume the overall bullish trend .
We also measure the wave 4 behaviour with our Elliottwave oscillator, which has pulled back within our pre-determined zone.
So overall we have identified, using our Elliott Wave Indicator suite for TradingView, a high probability long swing trading opportunity for HALO , Weekly Time Frame , with the following entry strategy:
We use our 6/4 MA High for initial starting point for long entries and take into consideration and recent pivots during the 4th wave pullback.
Long entry through $18.63
Stop Loss $17.63
Target $20.20
Giving a Risk to Reward of 1:1.7
ZEC poised to be the #1 Crypto?With the Development of HALO by the ZCASH team and a new listing announcement for ZEC on Binance US it looks like ZEC is having a great week. The latest TradingView Technical Analysis ideas mostly favor upwards movement but I'm curious how the latest tech advances are going to play out for ZCASH.
HALO from the ZCash dev team is a boon for the entire crypto industry which has implications reaching well beyond cryptocurrency. Few who understand the implications would dispute that this development alone was well worth the previously controversial founders reward that funds the Electric Coin Company and ZCash Foundation.
Additionally I'm seeing a lot more on privacy issues lately with ZEC starting to emerge with a consensus as the most secure for those with privacy concerns.
In my opinion the only thing ZCash is not ahead of the game is when it comes to marketing.
Will ZCash's technological dominance drive this coin to the top, or will their developers lack of ability to promote this coin and it's ground breaking features in a meaningful and perhaps more importantly in a way that people can understand the awesomeness of this project allow it to fade to obscurity?
Good Risk to RewardHALO saw poor demand into resistance followed by an increase in selling pressure. This is usually characteristic of DISTRIBUTION; however, price did not close below support. This is because demand exceeded supply.
This is a signs that BULLS are attempting to "absorb" supply.
Even in the face of indecision longs have an opportunity to buy support offering a good risk to reward.
Good Luck!
DSKX Begins To Rally After The Conference CallShares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products.
It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company, so if you haven't already, I highly encourage you to listen to today's conference call as soon as possible. Much larger company structure overall, significant increase in revenue, assets, cash flow and working capital with a very reputable management team to move the company forward. The fact that the current market cap is only 33M is what really gets me excited. Listen to the call to learn more:
The replay of the conference call can be heard by dialing 1-888-286-8010 in the United States and Canada or +1-617-801-6888 internationally, then referencing the Conference Passcode "56187013" A recording of the call can also be heard on the company website.
In the call, the DS Healthcare Group management team shared their motivations and answered questions relating to the business fundamentals on the Radiancy & Neova® deal, explaining how natural strategy alignment and synergies will lead to significant bottom line contribution.
The call was hosted by Mark Brockelman (CFO), Manny Gonzeles (CCO) and Renee Barch-Niles (CEO) and took place on Thursday, February 25th, 2016, at 8:30 a.m. EST.
-Renee Barch-Niles (CEO), an experienced CPG Executive who drove double-digit year-over-year growth in global food, drug, mass, club and specialty channels for Global companies such as Daymon Worldwide and Emilia Personal Care.
-Mark Brockelman (CFO) who has great experience in mergers and acquisitions, systems integration expertise and highly astute financial acumen. Mr. Brockelman Brockelman served as the Chief Financial Officer for National Dentex Corporation as well as the Senior Vice President/Chief Financial and Administrative Officer of the Miami Dolphins.
-Manny Gonzalez (CCO), a former top (NASDAQ: PG) Procter & Gamble executive managing a team of 7,000 sales representatives in the U.S., who has direct access to every major retailer in the country.
Acquisition Press Release Below:
finance.yahoo.com
For full disclose please visit: www.stockpicksnyc.com
